Aduro Clean Technologies Inc. reported that its revenue for the three‑month period ended November 30 2025 rose to $122,706, a 222% increase from $38,143 in the same quarter of 2025. The year‑to‑date revenue for the six months ending November 30 2025 reached $167,206, up 80% from $93,143 in the comparable period of 2024, driven largely by a 222% jump in non‑recurring customer engagement programs that generated additional sales of $84,500 in the quarter.
The company posted a loss from operations of $6,461,987 for Q2 2026, compared with $3,114,712 in Q2 2025, and a year‑to‑date loss of $12,787,005 versus $5,577,244 in the same period of 2024. GAAP earnings per share were a loss of C$0.21, missing analyst expectations of C$0.12 by C$0.09. The widening loss reflects increased investment in research and development, scale‑up activities, and the revaluation of derivative financial liabilities.
Chief Executive Officer Ofer Vicus highlighted progress on the company’s Next Generation Process Pilot Plant, noting that the plant’s commissioning is advancing and that a global site‑selection process for the future demonstration plant is underway. Chief Financial Officer Mena Beshay added that a U.S. public offering completed after quarter‑end raised gross proceeds of approximately US$20 million, which will be directed primarily toward advancing the demonstration plant program, continued R&D, and general corporate purposes.
Revenue growth was largely driven by the Hydrochemolytic™ platform’s application in plastics upcycling, renewable oil upgrading, and bitumen upgrading. However, the company’s revenue mix remained heavily weighted toward non‑recurring programs, and the company’s high burn rate—stemming from significant capital expenditures on property, plant, and equipment for the pilot plant—contributed to the widening operating loss. The company’s cash position improved markedly after the public offering, providing a stronger financial cushion for ongoing development.
Headwinds include the non‑recurring nature of the current revenue streams and the continued need for capital to scale the technology. Tailwinds are the substantial cash infusion, progress on the pilot and demonstration plant, and a strengthening capital position that supports future R&D and expansion. Management remains focused on advancing the Hydrochemolytic platform while managing burn, with an outlook that emphasizes continued investment in technology development and strategic growth opportunities.
The content on BeyondSPX is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.